BARNES-JEWISH HOSPITAL
WASHINGTON UNIVERSITY SCHOOL OF MEDICINE
About Us
News & Events
Maps & Locations
Contact Us
Google Search
PATIENT AND VISITOR INFORMATION
TREATMENT PROGRAMS
PREVENTION AND SCREENING
RESEARCH
HOW TO HELP
FOR HEALTH PROFESSIONALS
Go back to:
Home
Treatment Programs
Types of Cancer
Clinical Trial Search Results
Share
Lymphoma
NCI Information
Clinical Trials
Non-Hodgkin Lymphoma Trials
Hodgkin Lymphoma Trials
Bone Marrow Transplant (BMT) Trials
Support Groups
Effects of Treatment
Patient Stories
Bone Marrow and Stem Cell Transplantation
Treatment Team
NEW SEARCH
RETURN TO SEARCH RESULTS
Number:
201102317
Principal Investigator:
Bartlett, Nancy
Title:
A Randomized Phase II Study of Rituximab with ABVD Versus Standard ABVD for Patients with Advanced-Stage Classical Hodgkin Lymphoma with Poor Risk Features (IPS Score > 2)
Phase:
II
Disease Site:
Hodgkin's Lymphoma
Participating Site(s):
Main Campus
Map and Directions
St. Peters
Map and Directions
Contact:
800-600-3606 or
info@ccadmin.wustl.edu
Description:
The goal of this clinical research study is to compare the effectiveness of receiving adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) therapy alone to receiving ABVD with rituximab.
Up to 120 patients will take part in this study. Up to 10 will be enrolled at Washington University.
More Information:
(Links will take you off this web site)
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)